Mobile

RSS Feeds

Login
Email/Username:
Password:
Remember me
Forgot password?

Log In
Register
Register as a Guest
Register and Claim Your Subscription

Subscribe

Articles & Issues
o Articles In Press
o Current Issue
o Archive
o Supplements
Focuses
o Focus on Transplantation
o Focus on Basic Research

o






Focus on Clinical Nephrology
For Authors & Reviewers
o Author Information
o Author Financial Disclosure Form
o Permissions
o Submit a Manuscript
o Reviewer Information
For Readers
o About the Journal
o Contact Information
o Editorial Board
o New Content Alerts
o Pricing
For Advertisers
o Advertising Information
o Permissions
o Reprints
Companion Journals
o KI Supplements
Subscribe
o Subscription Information
o Become ISN Member Subscriber
ISN
Search Terms
Advanced Search
In This Issue
Search within
All Content
Search
Novel genetic predictors of diabetic CKD
Progress in identifying genetic factors that predispose patients with type 2 diabetes to develop
CKD has been frustratingly slow. The authors' novel 3-stage approach to a clinicogenomic data
set identified 3 novel genetic predictors of CKD in type 2 diabetes.
Pulmonary congestion common in nephrotic syndrome
Though patients with NS develop edema that can involve vital organs, it had been assumed that
the lungs are protected from NS-induced edema. The authors used chest ultrasound and
transthoracic impedance to measure lung water and found asymptomatic pulmonarycongestion is
pervasive in patients with NS.
AT1R blockade stops AKI transition to CKD
This provocative study suggests that treatment with angiotensin receptor blockers prior to AKI
may be a viable strategy to prevent subsequent CKD.
Kallistatin prevents diabetic nephropathy in mice
Yiu and co-workers tested whether inducing increased kallistatin expression in kidneys can
protect against development of nephropathy in the db/db mouse model of type 2 diabetes. The
data demonstrate that strategies to increase renal kallistatin expression may be a novel
therapeutic option to prevent diabetic kidney injury.
Previous slide
<
Next slide
>



Articles in Press
Most Cited
News
Keratins are novel markers of renal epithelial cell injury
Sonja Djudjaj, Marios Papasotiriou, Roman D. Bülow, Alexandra Wagnerova,
Maja T. Lindenmeyer, Clemens D. Cohen, Pavel Strnad, Dimitrios S. Goumenos,
Jürgen Floege, Peter Boor
DOI: http://dx.doi.org/10.1016/j.kint.2015.10.015
Publication stage: In Press Corrected Proof
Kidney International
AbstractFull-Text HTMLPDFSupplemental Materials
Polymorphisms in the lectin pathway of complement activation influence the
incidence of acute rejection and graft outcome after kidney transplantation
Déla Golshayan, Agnieszka Wójtowicz, Stéphanie Bibert, Nitisha Pyndiah, Oriol
Manuel, Isabelle Binet, Leo H. Buhler, Uyen Huynh-Do, Thomas Mueller, Jürg
Steiger, Manuel Pascual, Pascal Meylan, Pierre-Yves Bochud, Swiss Transplant
Cohort Study
DOI: http://dx.doi.org/10.1016/j.kint.2015.11.025
Publication stage: In Press Corrected Proof
Kidney International
AbstractFull-Text HTMLPDFSupplemental Materials
Complement receptor 3 mediates renal protection in experimental C3
glomerulopathy
Thomas D. Barbour, Guang Sheng Ling, Marieta M. Ruseva, Liliane FossatiJimack, H. Terence Cook, Marina Botto, Matthew C. Pickering
DOI: http://dx.doi.org/10.1016/j.kint.2015.11.024
Publication stage: In Press Corrected Proof
Kidney International
Open Access
AbstractFull-Text HTMLPDFSupplemental Materials
A label-free approach by infrared spectroscopic imaging for interrogating the
biochemistry of diabetic nephropathy progression
Vishal K. Varma, Andre Kajdacsy-Balla, Sanjeev K. Akkina, Suman Setty,
Michael J. Walsh
DOI: http://dx.doi.org/10.1016/j.kint.2015.11.027
Publication stage: In Press Corrected Proof
Kidney International
AbstractFull-Text HTMLPDFSupplemental Materials
Low levels of high-density lipoprotein cholesterol increase the risk of incident
kidney disease and its progression
Benjamin Bowe, Yan Xie, Hong Xian, Sumitra Balasubramanian, Ziyad Al-Aly
DOI: http://dx.doi.org/10.1016/j.kint.2015.12.034
Publication stage: In Press Corrected Proof
Kidney International
AbstractFull-Text HTMLPDFSupplemental Materials
View More Articles in Press
With the January 2016 issue, Elsevier will be the official publisher of Kidney International, an
official publication of the International Society of Nephrology. Read the full press release.
I am delighted that ISN managed to find a great publisher in Elsevier.
Considering the big changes happening in the field of medical publishing, it is
very reassuring that Kidney International is such an attractive journal to Elsevier.
ISN is proud to have such an important pillar to its leading Global Education
portfolio, currently delivering tailored education to a broad range of kidney
professionals worldwide, through publications, meetings and a content-rich
online portal.
David Harris, ISN Global Education Director
About KI
Kidney International (KI) is the official journal of the International Society of Nephrology.
Under the editorial leadership of Dr. Detlef O. Schlöndorff (USA), KI is one of the most cited
journals in nephrology and widely regarded as the world's premier journal on the development
and consequences of kidney disease.
KI is peer-reviewed and publishes original research in both basic science and clinical medicine.
These include the latest clinical studies on emerging developments in renal medicine and the
highest level of original research studies in therapy and epidemiology of acute and chronic
kidney failure, as well as their translational aspects and genetic basis. In addition relevant aspects
of renal physiology, cell biology, biochemistry, pathology, immunology, morphology and new
technological developments are reported with the over-all aim of informing the renal researcher
and the practicing nephrologist on all aspects of renal research.
The journal reflects the field through critical reviews and original articles, commentaries,
editorial updates on recent developments and news features, recommendations and guidelines
resulting from expert consensus meetings, aspects of nephrology from the developing world,
policy issues, remarkable images, and problem-focused articles for the diagnosis and treatment
of renal patients. Kidney International is published monthly.
More
About the International Society of Nephrology
The International Society of Nephrology (ISN) is a global not-for-profit membership-based
society dedicated to improving kidney care and reducing the incidence and impact of kidney
disease worldwide. Through its global network and programs, ISN brings together all regions of
the world in a collaborative effort in fighting and treating kidney disease on a global scale.
With 9,000 professional members from 129 countries, ISN represents a wide international
network. It provides an efficient platform for timely scientific exchange, debate and
communication between all healthcare professionals involved in preventing and treating kidney
disease. By collaborating with over 82 national and regional societies, ISN represents more than
20,000 professionals around the globe.
Since 1960, the ISN has been providing nephrologists worldwide with highly valuable services,
such as publications, meetings, capacity building programs, and has been spearheading concerted
awareness-generating efforts such as World Kidney Day.
Current Issue: February 2016
Volume 89, Issue 2
February 2016
Volume 89, Issue 2
Past Issues
New Content Alerts
Access this journal on ScienceDirect
List of Issues
Supports Open Access
This journal has an open archive
Learn more about open access options.
KI Supplements
Our companion journal, KI Supplements, focuses on sponsored, topical
content of interest to the nephrology community. The journal is complimentary to KI
subscribers.
2014 Impact Factor is 10.435
ISN World Congress
ISN World Congress of Nephrology 2017
Sustainability and Diversity
April 21 - 25, 2017
Mexico City, Mexico
Copyright © 2016 Elsevier Inc. except certain content provided by third parties. | Privacy Policy
| Terms & Conditions | About Us | Help & Contact
The content on this site is intended for health professionals.
Advertisements on this site do not constitute a guarantee or endorsement by the journal,
Association, or publisher of the quality or value of such product or of the claims made for it by
its manufacturer.